AbCellera
The Lab-based Research Scientist II will join the Vancouver team to bridge in vivo models and biological insights, supporting the design, execution, and analysis of in vivo studies to inform drug development decisions. This role involves collaborating with cross-functional teams to advance pipeline programs from hit identification through clinical trials. The position requires hands-on expertise in pharmacology and a commitment to rigorous, detail-driven science.
Headquarters
Vancouver, British Columbia, Canada
Company Size
501-1000 employees
Founded
2012
AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbCellera.
Right around the average for this role
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn
Dec 25, 2025
Translational Biologist
Isomorphic Labs
Associate Scientist, Translational Biology
Septerna
In Vivo Scientist
AstraZeneca
Advisor – RNA Preclinical Pharmacology, Ocular
Eli Lilly and Company
Sr. Director, Pharmacology
Flagship Pioneering, Inc.
Scientist, Immunology & Pharmacology (Hematologic Malignancies)
PharmaEssentia